Impulse Control Genes Linked to Addiction Risk, Rutgers Study Finds Most of the genetic risk for developing a substance use disorder stems from genes influencing brain processes related to reward, …
Genome
-
-
New Genetic Risk Score Better Predicts Diabetes, Obesity, and Related Health Risks A newly developed genetic risk score (PRS) is demonstrating improved accuracy in predicting the development of type 2 …
-
The Complex Genetics of Epilepsy: New Insights into a Common Neurological Disorder Epilepsy, a chronic neurological disorder affecting over 50 million people worldwide, is far more genetically complex than previously …
-
Decoding the Language of the Brain: How AI and Genetics Are Unlocking Communication’s Secrets Learning French, reading a novel, or simply chatting with friends – language is fundamental to the …
-
Low-Cost Infection Control Measures Show Promise in Combating Deadly Neonatal Sepsis A new study reveals that implementing a bundle of low-cost infection prevention and control (IPC) measures can temporarily disrupt …
-
Genetic Study Reveals Common Roots of Psychiatric Disorders A groundbreaking genetic analysis of over one million individuals has revealed shared biological underpinnings across 14 psychiatric conditions, challenging traditional diagnostic boundaries. …
-
Most Pandemic Viruses Jump to Humans Without Prior Adaptation, UC San Diego Study Finds A latest University of California San Diego study published in Cell challenges the long-held assumption that …
-
Somatic Genomics: Uncovering the Roots of Disease and Fresh Therapeutic Pathways Scientists are increasingly recognizing the pivotal role of somatic mutations – genetic changes that occur after conception – in …
-
Lettuce-Delivered GLP-1s: A Potential Game Changer for Diabetes and Obesity Treatment Glucagon-like peptide-1 (GLP-1) receptor agonists have rapidly become a focal point in the treatment of both type 2 diabetes …
-
Wisdom Bioscience Launches Scientific Advisory Board to Advance Oral Cancer Diagnostics IRVINE, Calif. & DARESBURY, England – March 2, 2026 – Wisdom Bioscience, Inc., a biotechnology company focused on non-invasive …